Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to β-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy

Circulation

Volumn 101, Issue 16, 2000, Pages 1925-1930

  Shinke, Toshiro ^a   Takaoka, Hideyuki ^a   Takeuchi, Motoshi ^a   Hata, Katsuya ^a   Kawai, Hiroya ^a   Okubo, Hideaki ^a   Kijima, Yoichi ^a   Murata, Takeomi ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contractility; Heart failure; Nitric oxide; Oxygen

Indexed keywords

DOBUTAMINE; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INOTROPISM; INTRACORONARY INFUSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0034712641     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.16.1925     Document Type: Article

References (27)

1. Balligand JL, Kelley RA, Marsden PA, Smith TW, Michael T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
2. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding ASE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993; 265:H176-H182.
3. Hare JM, Keaney JF, Balligand JL, Loscalzo J, Smith TW. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 1995;95:360-366.
4. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
5. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of β-adrenergic inotropic responsiveness. Circulation. 1998;97:161-166.
6. Xie Y-W, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res. 1996;79:381-387.
7. Zhang X, Xie Y-W, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation. 1997;95:176-182.
8. Sherman AJ, Davis CA III, Klocke FJ, Harris KR, Srinivasan G, Yaacoub AS, Quinn DA, Ahlin KA, Jang JJ. Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation. 1997;95: 1328-1334.
9. Suga H. Ventricular energetics. Physiol Rev. 1990;70:247-277.
10. Baim DS, Rothman MT, Harrison DC. Simultaneous measurement of coronary venous blood flow and oxygen saturation during transient alterations in myocardial oxygen supply and demand. Am J Cardiol. 1982; 49:743-752.
11. Takaoka H, Takeuchi M, Odake M, Hayashi Y, Hata K, Mori M, Yokoyama M. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation. 1993;87:59-69.
12. Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985;56:586-595.
13. Raff GL, Glantz SA. Volume loading shows left ventricular isovolumic relaxation rate: evidence of load-dependent relaxation in the intact dog heart. Circ Res. 1981;48:813-824.
14. Mirsky I, Pasipoularides A. Clinical assessment of diastolic function. Prog Cardiovasc Dis. 1990;32:291-318.
15. Habib FM, Spingall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
16. Heywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
17. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet. 1994;344: 373-374.
18. 2+ current. J Biol Chem. 1993;268:26286-26295.
19. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931-936.
20. Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, Hasenfuβ G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. JAm Coll Cardiol. 1998;32:955-963.
21. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363-380.
22. Saeki A, Recchia FA, Senzaki H, Kass DA. Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart. J Physiol. 1996;491:455-463.
23. Prendergast BD, Sagach VF, Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation. 1997;96:1320-0329.
24. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation. 1994;89:2070-2078.
25. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JGF. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet. 1994;344:371-373.
26. Kass DA, Beyer R, Lankford E, Heard M, Maughan WL, Sagawa K. Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation. 1989;79:167-178.
27. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure? J Am Coll Cardiol. 1996;28:1323-1327.